Target intelligence / Profile preview

Membrane phospholipid fatty acid incorporation site

Molecular classification
Lipid substrate site, Enzymatic active site (LPLAT/MBOAT), Membrane component
01

Overview

The membrane phospholipid fatty acid incorporation site refers to the biochemical position within cellular membrane phospholipids, typically the sn-2 position of the glycerol backbone, where fatty acids are esterified during the remodeling process known as the Lands' cycle. This site is the primary point of entry for polyunsaturated fatty acids (PUFAs) like arachidonic acid and eicosapentaenoic acid (EPA) into the membrane bilayer, a process catalyzed by various lysophospholipid acyltransferases (LPLATs) such as LPCAT3 and MBOAT7. The incorporation of specific fatty acids at this site is a critical determinant of membrane biophysical properties, including fluidity and permeability, and serves as a regulatory reservoir for bioactive lipid signaling molecules. Pharmacologically, this site is the functional target for omega-3 fatty acid supplements, which compete with pro-inflammatory arachidonic acid for incorporation, thereby modulating the cellular inflammatory response and cardiovascular health.

Other names
Phospholipid fatty acid incorporation siteMembrane phospholipid fatty acid turnover siteLands' cycle incorporation sitesn-2 position of membrane phospholipids
02

Mechanism of action

Competitive incorporation into the sn-2 position of phospholipids to displace arachidonic acid and reduce pro-inflammatory eicosanoid precursors.

03

Biological functions

Membrane remodelingFatty acid traffickingEicosanoid precursor regulationMaintenance of membrane fluidityLands' cycle mediation
04

Disease associations

Cardiovascular diseaseInflammationHypertriglyceridemiaNonalcoholic fatty liver disease (NAFLD)Atherosclerosis
05

Safety considerations

Increased bleeding risk (at high doses of omega-3)Atrial fibrillation riskGastrointestinal upset
06

Interacting drugs

Eicosapentaenoic acid (EPA)

4 more in the full profile.

07

Biomarkers

Erythrocyte membrane fatty acid profileOmega-3 index (EPA+DHA levels)Arachidonic acid to EPA ratio

Beyond the preview

Go deeper on Membrane phospholipid fatty acid incorporation site.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane phospholipid fatty acid incorporation site.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call